Search research articles
Contact Us
Filters
Showing results (81-90 of 91) with videos related to
Page
of 10
Sort By:
Plos One
|
September 15, 2017
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires
Bin Jia, Lisa K McNeil, Christopher D Dupont, et al.
European Journal of Clinical Nutrition
|
August 12, 2010
Vitamin D status and measures of cognitive function in healthy older European adults
K M Seamans, T R Hill, L Scully, et al.
The Lancet. Infectious Diseases
|
September 6, 2020
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial
Judith Absalon, Nathan Segall, Stan L Block, et al.
The Journal of Infectious Diseases
|
February 20, 2019
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization
Ed T Buurman, Yekaterina Timofeyeva, Jianxin Gu, et al.
Science Translational Medicine
|
July 9, 2025
Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques
Catherine Jacob-Dolan, David Hope, Jinyan Liu, et al.
Plos One
|
January 15, 2019
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Nature
|
January 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature
|
September 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 91) with videos related to
Sort By:
Page
of 10
Plos One
|
September 15, 2017
Longitudinal multiparameter single-cell analysis of macaques immunized with pneumococcal protein-conjugated or unconjugated polysaccharide vaccines reveals distinct antigen specific memory B cell repertoires
Bin Jia, Lisa K McNeil, Christopher D Dupont, et al.
European Journal of Clinical Nutrition
|
August 12, 2010
Vitamin D status and measures of cognitive function in healthy older European adults
K M Seamans, T R Hill, L Scully, et al.
The Lancet. Infectious Diseases
|
September 6, 2020
Safety and immunogenicity of a novel hexavalent group B streptococcus conjugate vaccine in healthy, non-pregnant adults: a phase 1/2, randomised, placebo-controlled, observer-blinded, dose-escalation trial
Judith Absalon, Nathan Segall, Stan L Block, et al.
The Journal of Infectious Diseases
|
February 20, 2019
A Novel Hexavalent Capsular Polysaccharide Conjugate Vaccine (GBS6) for the Prevention of Neonatal Group B Streptococcal Infections by Maternal Immunization
Ed T Buurman, Yekaterina Timofeyeva, Jianxin Gu, et al.
Science Translational Medicine
|
July 9, 2025
Adenovirus and mRNA vaccines as well as mucosal boosting improve protective efficacy against influenza virus challenge in macaques
Catherine Jacob-Dolan, David Hope, Jinyan Liu, et al.
Plos One
|
January 15, 2019
Molecular epidemiology and expression of capsular polysaccharides in Staphylococcus aureus clinical isolates in the United States
Naglaa Mohamed, Yekaterina Timofeyeva, Dorota Jamrozy, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Nature
|
January 20, 2021
Publisher Correction: COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Nature
|
September 30, 2020
COVID-19 vaccine BNT162b1 elicits human antibody and T<sub>H</sub>1 T cell responses
Ugur Sahin, Alexander Muik, Evelyna Derhovanessian, et al.
Page
of 10